2-Hydroxy benzimidazole → HCID 66650118, compound
Reaction equation
[N:1]1[CH:6]=[CH:5][N:4]=[CH:3][C:2]=1[C@@H:7]([NH:9][C:10]([C:12]1[CH:13]=[C:14]([C:19]2[CH:24]=[CH:23][C:22]([CH3:25])=[CH:21][CH:20]=2)[CH:15]=[C:16](I)[CH:17]=1)=[O:11])[CH3:8].[NH:26]1[C:30]2[CH:31]=[CH:32][CH:33]=[CH:34][C:29]=2[NH:28][C:27]1=[O:35].[O-]P([O-])([O-])=O.[K+].[K+].[K+].CNC1CCCCC1NC>C1(C)C=CC=CC=1.[Cu]I>[N:1]1[CH:6]=[CH:5][N:4]=[CH:3][C:2]=1[C@@H:7]([NH:9][C:10]([C:12]1[CH:13]=[C:14]([C:19]2[CH:24]=[CH:23][C:22]([CH3:25])=[CH:21][CH:20]=2)[CH:15]=[C:16]([N:26]2[C:30]3[CH:31]=[CH:32][CH:33]=[CH:34][C:29]=3[NH:28][C:27]2=[O:35])[CH:17]=1)=[O:11])[CH3:8]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 110 °C
Procedure
5-Iodo-4′-methyl-biphenyl-3-carboxylic acid ((S)-1-pyrazin-2-yl-ethyl)-amide (110 mg, 0.25 mmol) was dissolved in toluene (3 mL) and 1,3-dihydro-benzoimidazol-2-one (135 mg, 1.0 mmol), and CuI (15 mg), K3PO4 (212 mg, 1.0 mmol) and 1,2-bis(methylamino)cyclohexane (0.1 mL) were added. The reaction mixture was stirred at 110° C. overnight, then cooled to room temperature and partitioned between water and ethyl acetate. The organic layer was separated and concentrated under reduced pressure and the residue was purified by preparative thin layer chromatography (7% methanol in dichloromethane) to give 20 mg (185 yield overall) of 4′-methyl-5-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-biphenyl-3-carboxylic acid ((S)-1-pyrazin-2-yl-ethyl)-amide MS (M+H)=450.
Workup
- temperaturecooled to room temperature
- custompartitioned between water and ethyl acetate
- customThe organic layer was separated
- concentrationconcentrated under reduced pressure
- customthe residue was purified by preparative thin layer chromatography (7% methanol in dichloromethane)
Sources & evidence
- ORD record
- ord-dd46705fc52845b2aa67d7c33489743b
- Source dataset
- uspto-grants-2012_01
- Patent number
- US08093275B2
Reaction notes
Loading…